tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MDWD Stock Latest News

MediWound Calls February 19, 2026 Extraordinary Meeting to Expand 2024 Share Incentive Plan
Company AnnouncementsMediWound Calls February 19, 2026 Extraordinary Meeting to Expand 2024 Share Incentive Plan
3d ago
6K
MDWD
Mediwound: NexoBrid Capacity Expansion and EscharEx Pipeline Catalysts Support Buy Rating and $36 Target
PremiumRatings
Mediwound: NexoBrid Capacity Expansion and EscharEx Pipeline Catalysts Support Buy Rating and $36 Target
5d ago
MDWD
MediWound Lays Out Growth Path With EscharEx Progress, NexoBrid Scale-Up and Strong Cash Position
PremiumCompany Announcements
MediWound Lays Out Growth Path With EscharEx Progress, NexoBrid Scale-Up and Strong Cash Position
6d ago
6K
MDWD
MediWound sees FY25 revenue $17M, consensus $22.98M
PremiumThe Fly
MediWound sees FY25 revenue $17M, consensus $22.98M
6d ago
MDWD
MediWound sees FY26 revenue $24-26M, consensus $28.8M
PremiumThe Fly
MediWound sees FY26 revenue $24-26M, consensus $28.8M
6d ago
MDWD
MediWound reports clinical data on NexoBrid’s effectiveness
PremiumThe FlyMediWound reports clinical data on NexoBrid’s effectiveness
1M ago
MDWD
MediWound: Strong Financial Health and Market Opportunities Drive Buy Rating
Premium
Ratings
MediWound: Strong Financial Health and Market Opportunities Drive Buy Rating
2M ago
MDWD
MediWound price target raised to $36 from $31 at H.C. Wainwright
Premium
The Fly
MediWound price target raised to $36 from $31 at H.C. Wainwright
2M ago
MDWD
MediWound’s Q3 2025: Growth and Strategic Advances
PremiumCompany Announcements
MediWound’s Q3 2025: Growth and Strategic Advances
2M ago
MDWD
Mediwound’s Strong Q3 Performance and Strategic Advancements Justify Buy Rating
PremiumRatings
Mediwound’s Strong Q3 Performance and Strategic Advancements Justify Buy Rating
2M ago
MDWD
MediWound’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
MediWound’s Earnings Call: Growth Amid Challenges
2M ago
MDWD
MediWound Announces Q3 2025 Financial Results and Facility Expansion
PremiumCompany Announcements
MediWound Announces Q3 2025 Financial Results and Facility Expansion
2M ago
6K
MDWD
MediWound reports Q3 EPS (24c), consensus (98c)
PremiumThe FlyMediWound reports Q3 EPS (24c), consensus (98c)
2M ago
MDWD
MDWD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
MDWD Upcoming Earnings Report: What to Expect?
2M ago
MDWD
MediWound’s Strategic Expansion and NexoBrid’s Market Potential Drive Buy Rating
Premium
Ratings
MediWound’s Strategic Expansion and NexoBrid’s Market Potential Drive Buy Rating
2M ago
MDWD
MediWound completes commissioning of expanded GMP manufacturing facility
PremiumThe Fly
MediWound completes commissioning of expanded GMP manufacturing facility
3M ago
MDWD
MediWound’s EscharEx Study: A Potential Game-Changer for Venous Leg Ulcers
PremiumCompany Announcements
MediWound’s EscharEx Study: A Potential Game-Changer for Venous Leg Ulcers
3M ago
MDWD
MediWound’s New Study on EscharEx: A Potential Game-Changer for Venous Leg Ulcers
PremiumCompany Announcements
MediWound’s New Study on EscharEx: A Potential Game-Changer for Venous Leg Ulcers
3M ago
MDWD
MediWound Raises $30 Million Through Share Offering to Boost EscharEx® Initiatives
PremiumCompany Announcements
MediWound Raises $30 Million Through Share Offering to Boost EscharEx® Initiatives
4M ago
6K
MDWD
MediWound Announces $30 Million Direct Offering to Boost Operations
PremiumCompany AnnouncementsMediWound Announces $30 Million Direct Offering to Boost Operations
4M ago
6K
MDWD
MediWound announces $30M registered direct offering
Premium
The Fly
MediWound announces $30M registered direct offering
4M ago
MDWD
MediWound down 8% at $16.50 following offering
Premium
The Fly
MediWound down 8% at $16.50 following offering
4M ago
MDWD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >